保健常识
快速导航
频道
女性
减肥
育儿
保健
美容
妇科
饮食
中医
肿瘤
资讯
男性
诊疗
呼吸科
心血管
肝病科
更多
服务
问医生
就医助手
药品通
疾病百科
名医在线
简单生活
热门疾病
高血压
阴道炎
肩周炎
脂肪肝
小儿咳嗽
糖尿病
健康科普
科普基地
关注39减肥健康运动

查看更多相关内容

取消关注
首页 > 男性 > 保健常识

查出脂肪肝怎么办?提醒:这么“吃”可有效减少脂肪,改善血糖

举报/反馈
2021-07-16 10:10:3539健康网


参考资料:

[1]Herman, M.A., Metabolic liver disease — what’s in a name? Nature Reviews Endocrinology, 2020.

[2]Jelena Todoric et al. (2020) Fructose stimulated de novo lipogenesis is promoted by inflammation. Nature Metabolism

[3]Giovanni Targher, et al., (2021). Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. The Lancet Gastroenterology & Hepatology

[4]非酒精性脂肪性肝病防治指南(2018更新版)[J].传染病信息,2018,31(05):393-402+420.

[5]Parthasarathy, G. et al. “Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.” Hepatology Communications 4 (2020): 478 - 492.

[6]Younossi, Z. et al. “Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.” Clinical Gastroenterology & Hepatology 17 (2019): 748–755.e3.

[7]Younossi, Z. et al. “Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.” Hepatology 69 (2019): n. pag.

[8]Younossi, Z. et al. “Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.” Transplantation (2019): n. pag.

[9]Harrison, S. et al. “NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis.” Hepatology (Baltimore, Md.) 71 (2019): 1198 - 1212.

[10]Choi, Hannah S. J. et al. “Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B.” Hepatology 71 (2019): n. pag.

[11]Diehl, A. and Christopher Day. “Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.” The New England Journal of Medicine 377 (2017): 2063–2072.

[12]Kim, D. et al. “Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease.” Liver International 39 (2019): 332 - 341.

[13]Younossi, Z. et al. “Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.” Hepatology 68 (2018): n. pag.

39健康网专业医疗保健信息平台 优质健康资讯门户网站  
快速通道
相关推荐39精品39热文
自测
查看全部
推荐专家
查看更多
推荐医院
查看更多
健康资讯热门资讯